Bromperidol: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|An antipsychotic medication used in the treatment of schizophrenia and other disorders.}} | |||
== | ==Bromperidol== | ||
[[File:Bromperidol.svg|thumb|right|Chemical structure of Bromperidol]] | |||
'''Bromperidol''' is a [[typical antipsychotic]] medication primarily used in the treatment of [[schizophrenia]] and other psychotic disorders. It belongs to the [[butyrophenone]] class of antipsychotics, which also includes [[haloperidol]]. | |||
==Pharmacology== | ==Pharmacology== | ||
Bromperidol | Bromperidol acts as a potent [[dopamine receptor antagonist]], particularly at the [[D2 receptor|dopamine D2 receptors]]. This action is thought to be responsible for its antipsychotic effects. By blocking dopamine receptors in the brain, bromperidol helps to reduce symptoms such as hallucinations, delusions, and thought disorders. | ||
==Clinical Use== | |||
Bromperidol is used in the management of schizophrenia and other conditions characterized by psychosis. It is effective in reducing both positive and negative symptoms of schizophrenia. The medication is typically administered orally, but it can also be given via injection in certain clinical settings. | |||
==Side Effects== | ==Side Effects== | ||
Like other antipsychotics, | Like other typical antipsychotics, bromperidol can cause a range of side effects. Common side effects include [[extrapyramidal symptoms]] such as [[tremor]], [[rigidity]], and [[bradykinesia]]. Long-term use may lead to [[tardive dyskinesia]], a condition characterized by involuntary, repetitive body movements. Other potential side effects include [[sedation]], [[weight gain]], and [[anticholinergic effects]] such as dry mouth and constipation. | ||
== | ==History== | ||
Bromperidol was developed in the 1960s as part of the butyrophenone class of antipsychotics. It was introduced as a treatment option for schizophrenia and has been used in various countries around the world. Its development followed the success of haloperidol, another butyrophenone antipsychotic. | |||
* [[Antipsychotic]] | |||
* [[Schizophrenia]] | ==Related pages== | ||
* [[Dopamine]] | * [[Antipsychotic]] | ||
* [[Schizophrenia]] | |||
* [[ | * [[Dopamine receptor antagonist]] | ||
* [[Butyrophenone]] | |||
[[Category:Antipsychotics]] | [[Category:Antipsychotics]] | ||
[[Category:Butyrophenones]] | [[Category:Butyrophenones]] | ||
Latest revision as of 03:35, 13 February 2025
An antipsychotic medication used in the treatment of schizophrenia and other disorders.
Bromperidol[edit]
Bromperidol is a typical antipsychotic medication primarily used in the treatment of schizophrenia and other psychotic disorders. It belongs to the butyrophenone class of antipsychotics, which also includes haloperidol.
Pharmacology[edit]
Bromperidol acts as a potent dopamine receptor antagonist, particularly at the dopamine D2 receptors. This action is thought to be responsible for its antipsychotic effects. By blocking dopamine receptors in the brain, bromperidol helps to reduce symptoms such as hallucinations, delusions, and thought disorders.
Clinical Use[edit]
Bromperidol is used in the management of schizophrenia and other conditions characterized by psychosis. It is effective in reducing both positive and negative symptoms of schizophrenia. The medication is typically administered orally, but it can also be given via injection in certain clinical settings.
Side Effects[edit]
Like other typical antipsychotics, bromperidol can cause a range of side effects. Common side effects include extrapyramidal symptoms such as tremor, rigidity, and bradykinesia. Long-term use may lead to tardive dyskinesia, a condition characterized by involuntary, repetitive body movements. Other potential side effects include sedation, weight gain, and anticholinergic effects such as dry mouth and constipation.
History[edit]
Bromperidol was developed in the 1960s as part of the butyrophenone class of antipsychotics. It was introduced as a treatment option for schizophrenia and has been used in various countries around the world. Its development followed the success of haloperidol, another butyrophenone antipsychotic.
